Shareholders have been taking profit from beneficiaries of the pandemic and there are concerns of a more challenging outlook ahead for some, although others appear to have a very bright future as the pandemic has accelerated growth into new markets.
Tristel: doing well, but an overly cautious outlook?Tristel (LON:TSTL), the manufacturer of infection prevention products, issued a positive trading update for the year ended 30 June 2020, although the market was clearly expecting more and the outlook somewhat more cautious than anticipated. With increasing demand for many of its products over the pandemic results will 9as anticipated) be ahead of market expectations, with revenue expected to be up 21% to at least £31.6m (forecast £30m) and adjusted pre-tax profit up a similar amount to £6.8m. Revenues from overseas markets increased by 32% and contributed 60% of total revenues - a…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login